Introduction
During repeated interactions with caregivers, children develop stable cognitive-emotional schemas of their caregivers' availability for reducing stress and providing comfort and protection in potentially threatening situations (Bowlby, 1973) . In adulthood, differences in acquired cognitive-emotional schemas position an individual on two broad attachment dimensions -attachment anxiety and attachment avoidance (Mikulincer and Florian, 1995; Van IJzendoorn, 1995; Collins, 1996; Lemay and Dudley, 2011) . Attachment anxiety provides a cognitive-emotional model about the self, such that individuals higher on attachment anxiety are chronically worried about being rejected and unloved. Attachment avoidance, in contrast, provides a model about others, such that individuals lower on attachment avoidance feel they can depend on others to be available when needed, and are comfortable with closeness and intimacy. Attachment avoidance forms the basis for the regulation of affect vis-à-vis others, and for (lack of) social approach. Although Psychoneuroendocrinology (2012) 37, 871-880 
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What we now call attachment may have arisen from physiological solutions to simpler problems related to survival and reproduction (Uvnas-Moberg, 1998; Bartz et al., 2010a) . Mammalian reproduction requires a particularly intense investment of time and energy, and in humans and some other mammals, involves a commitment to a specific infant. Accordingly, the association between reproduction and social bonding may have contributed, in an evolutionary sense, to the selection of neurochemical systems involved in attachment behaviors (Carter, 1998; Young et al., 2001) . One such neurochemical is oxytocin, a nine amino-acid, cyclic neuropeptide produced in the hypothalamus and released into the blood stream from axon terminals and into the brain from dendrites of hypothalamic neurons (Donaldson and Young, 2008; Heinrichs et al., 2008 ). Oxytocin's targets include the amygdala, hippocampus, and regions of the spinal cord that regulate the parasympathic branch of the autonomic nervous system (Ludwig and Leng, 2006; Neumann, 2008; Roderigues et al., 2009) . Oxytocin interacts with the hypothalamic-pituitary-adrenal axis to attenuate stress responses (Uvnas-Moberg, 1998; Heinrichs et al., 2003; Kirsch et al., 2005; Neumann, 2008) , with dopaminergic, reward processing circuits in the nucleus accumbens shell and in the ventral tegmental area (Skuse and Gallagher, 2005) , and with brain areas involved in the development of empathy such as the inferior frontal gyrus and ventromedial prefrontal cortext (Baumgartner et al., 2009; Hurlemann et al., 2010; Riem et al., 2011; Shamay-Tsoory, 2011) .
Several studies suggest a role for oxytocin in adult attachment formation and maintenance. Plasma oxytocin negatively relates to attachment anxiety and avoidance (Tops et al., 2007) , and intranasal oxytocin compared to placebo lowers post-test attachment avoidance in insecurely attached males (Buchheim et al., 2009) . Furthermore, there is a clear role for oxytocin in the development of parentchild attachment. Intranasally administered oxytocin (versus placebo) made fathers more stimulating of their child's exploration (Naber et al., 2010) , and activated neural circuitries related to empathy in women exposed to infant crying (Riem et al., 2011) . In naturalistic settings, Feldman et al. (2007) showed that plasma oxytocin during pregnancy and postpartum predicted maternal bonding behaviors (e.g., gaze, vocalizations, positive affect), affectionate touch, and attachment-related thoughts. Gordon et al. (2010) added to this that paternal oxytocin levels correlated with the degree of stimulatory parenting behaviors (e.g., proprioceptive contact, tactile stimulation, and object presentation), and Feldman et al. (2010) showed that parental and infant oxytocin levels were correlated and these related, in turn, to greater affect synchrony and infant social engagement.
In addition to mediating parent-child attachment formation and maintenance, oxytocin also interacts with adult attachment style. Compared to mothers with insecure attachment, those with secure attachment (classified as low on both attachment anxiety and avoidance) had greater activation in the ventral striatum and the medial prefrontal cortex when exposed to pictures of toddlers, and activity in these reward processing regions correlated with blood plasma oxytocin (Strathearn et al., 2009) . Along similar lines, intranasal oxytocin increased positive memories about maternal care among low attachment anxiety adults, and increased negative memories about maternal care among high attachment anxiety individuals (Bartz et al., 2010a) . Apparently, especially for securely attached individuals, both positive and negative affective cues related to their infant and/or childhood may act as an incentive signal, reinforcing and motivating (working models of) responsive maternal care.
The intimate interplay between feelings of attachment, oxytocin, and bonding, opens up the possibility that oxytocin interacts with feelings of attachment in predicting social cognition, motivation, and behavioral tendencies in encounters with non-family protagonists such as colleagues, customers, teammates, bystanders, and passersby-all those we know little about yet whose behaviors influence our outcomes and our behavioral actions affect theirs. Such social interactions can be modeled as a social dilemma, in which two (or more) individuals simultaneously decide to cooperate or not with their protagonist. The dilemma occurs because mutual cooperation leads to better payoffs to individual and protagonist than mutual non-cooperation, but unilateral non-cooperation generates higher personal payoff than unilateral cooperation. Accordingly, in this social dilemma, and the many social exchange settings it models, failure to cooperate is due to (i) the greedy desire to exploit the protagonist's possible cooperative choice or (ii) betrayal aversion, or the fear of being exploited by the protagonist's non-cooperative choice (Coombs, 1973; Komorita and Parks, 1995) . Whereas there is little reason to assume attachment anxiety and/or avoidance to predict greed, both attachment anxiety and avoidance may be related to betrayal aversion. Attachment anxiety may be related to betrayal aversion because of the chronic feeling that one is unworthy of other's cooperativeness (Bartz et al., 2010b) . Attachment avoidance may be related to betrayal aversion because of the chronic feeling that one cannot depend on others. Especially the latter feeling may be susceptible to modulation by oxytocin. In general, oxytocin reduces betrayal aversion (Kosfeld et al., 2005; Baumgartner et al., 2008; De Dreu et al., 2010) , and approach motivation (Kemp and Guastella, 2011) . Provided protagonists are not depicted as untrustworthy or competitive, oxytocin promotes behavioral expressions of trust (Mikolajczak et al., 2010 ; also see Kosfeld et al., 2005; DeClerck et al., 2010) , and tendencies to affiliate (Kemp and Guastella, 2011; De Dreu et al., 2011a , 2011b . Together with its general anxiolytic effects , oxytocin thus reduces betrayal aversion and increases affiliation tendencies, and this should be particularly so among individuals with higher attachment avoidance.
The above suggests three hypotheses. Hypothesis 1 is that oxytocin increases cooperation especially among individuals with high attachment avoidance. Hypothesis 2 is that especially among individuals with higher attachment avoidance, oxytocin (2a) increases trust and lowers betrayal aversion, and (2b) strengthens affiliation tendencies. Finally, Hypothesis 3 is that the moderating effect of oxytocin on the attachment avoidance -cooperation relationship is mediated by (3a) betrayal aversion and/or (3b) affiliation tendencies.
Methods and materials

Overview
Hypotheses were tested in a double-blind, placebo-controlled between-subjects design in which healthy males completed validated measures of attachment anxiety and avoidance, 2 received intranasal oxytocin or placebo, and made three private choices between cooperation and noncooperation towards an unknown protagonist who also decided between cooperation and non-cooperation. Decision making had financial consequences. Following decision making, participants reported their betrayal aversion, affiliation tendencies, mood states, and indicated their (post-test) attachment style.
Subjects
The experiment was approved by the University ethics committee, and participants provided informed consent prior to the experiment. Males (N = 77; M = 20.81 years) received s10 for participation, and earnings from the decision task. Exclusion criteria were medical or psychiatric illness, prescription-based medication, smoking more than five cigarettes per day, and drug or alcohol abuse. Participants were instructed to refrain from smoking or drinking (except water) for 2 h before the experiment. All sessions took place between noon and 4 PM.
Test medication
Participants self-administered a single intranasal dose of 24 IU oxytocin (Syntocinon-Spray, Novartis; 3 puffs per nostril, each with 4 IU oxytocin) or placebo 35 min before the start of the experiment. The placebo contained all the active ingredients except for the neuropeptide, and was prepared adhering to the European Union GMP and GCP guidelines.
Procedure, measures, and tasks
Participants were seated in individual cubicles so they could neither see nor communicate with others, signed an informed consent, and self-administered the medication (placebo or oxytocin, double-blind randomized) under experimenter supervision. The experimenter left and participants completed unrelated tests. Effects of oxytocin plateau approximately 30-40 min after administration (Baumgartner et al., 2008) . Accordingly, after 35 min the computer switched to the experimental task. Participants read instructions, keyed in responses, and then were fully debriefed, paid, and dismissed.
Prior to the laboratory experiment, participants completed a test battery that included the revised 18-item Adult Attachment Style questionnaire (AAS; Collins, 1996) . Ratings on the 12 items assessing attachment avoidance (i.e., fear of closeness and fear of dependency) were averaged into one index (Cronbach's a = 0.84); ratings on the 6 remaining items were averaged into an index of attachment anxiety (Cronbach's a = 0.78) (all items 1 = not at all to 5 = very strong). Attachment avoidance correlated with attachment anxiety (r = 0.398, p < .001).
The experimental task involved an incentivized social dilemma. Each participant was randomly paired to another participant present in another cubicle, and informed that decisions would remain anonymous. Participants were told that they and the other individual would simultaneously and without communication choose between A (denoting cooperation) and B (denoting non-cooperation), that the combination of own and other's choice would determine each person's payoff, and that financial earnings would be paid at the end of the experiment. A table showed that joint cooperation (AA; s3 to each individual) yielded more than joint defection (BB; s1 to each individual), but unilateral cooperation (AB; s0 to the cooperating individual) yielded lowest, and unilateral defection (BA; s4 to the defecting individual) yielded highest outcomes. Non-cooperation here is driven by the desire to avoid s0 (fear, distrust) and/or the desire to obtain s4 (greed; Coombs, 1973; De Dreu et al., 2010) .
Following instructions, participants were quizzed about their understanding of the task. Specifically, for each possible combination of choices participants were asked to indicate their earning, and that of their partner. Following each answer, the correct answer was displayed and participants moved on with the next quiz-question. Analyses of participants' answers revealed that no participant made more than one error, and errors were never made in the last and before last question. From this it is concluded that participants understood the social dilemma. Following the quiz, participants were told that they would be asked several times to make a choice between A and B, and that one of their decisions would be randomly selected for actual pay. It was clarified that for all decisions they were paired with the same partner, and that no feedback about other's decisions would be provided. Decision making was self-paced, with random waiting time of 10-30 s in between decision prompts. In total, participants were asked three times to make a choice--cooperation thus ranges from 0 to 3.
In addition to cooperation, the experiment assessed a number of other dependent variables with a post-task questionnaire (all items 1 = not at all to 5 = very much). Trust was assessed with three items (''I expected the other player to choose Option A'' [the cooperative choice]; ''I trusted the other player was motivated to seek good outcomes for both of us,'' and ''I felt the other player could not be relied upon'' [reverse coded]; Cronbach's a = 0.87). The related construct of betrayal aversion was measured with two items (''During decision making I tried to minimize my losses'' and ''During decision making, I worried the other would exploit me;'' r[77] = 0.67). Affiliation tendency was assessed with three items (''I think it'll be fun to do another task with this partner,'' ''I feel my partner and I have a lot in common,'' and ''I feel connected to my partner;'' Cronbach's a = 0.84), and how calm/at ease, hostile, and happy they felt (each three items, Cronbach's a > 0.73). Finally, to examine whether treatment influences attachment (Buchheim et al., 2009) , participants were presented with Hazan and Shaver's (1987) scenarios that briefly describe the prototypical secure, anxious, and avoidant attachment style (HS-Secure ''I find it relatively easy to get close to others and am comfortable depending on them, and having them depend me. I don't often worry about being abandoned or about someone getting too close to me;'' HSAnxious: ''I find that others are reluctant to get as close as I would like. I often worry that my partner doesn't really love me or won't stay with me. I want to merge completely with another person, and this desire sometimes scares people away;'' HS-Avoidant: I am somewhat uncomfortable being close to others; I find it difficult to trust them completely, difficult to allow myself to depend on them. I am nervous when anyone gets too close, and often, love partners want me to be more intimate than I feel comfortable being.''). Participants indicated which scenario best described themselves. Table 1 provides the means, standard deviations and zeroorder correlations for all dependent variables. A few things are noteworthy. First, baseline measures of attachment anxiety and attachment avoidance are unrelated to treatment (see Table 1 ). Second, whereas attachment anxiety is not related to trust and cooperation, attachment avoidance is-higher attachment avoidance negatively relates to cooperation, trust, and feeling at ease; attachment avoidance positively relates to betrayal aversion and hostility. Third, treatment is unrelated to any of the dependent variables, which fits the recent insight that effects of oxytocin depend on context and person (Bartz et al., 2011) . Fourth, cooperation and trust are not related to affiliation tendencies, but strongly related to betrayal aversion. Accordingly, only betrayal aversion qualifies as a potential mediator of hypothesized treatment Â attachment avoidance interactions on cooperation (as predicted in Hypothesis 3a; Baron and Kenny, 1986) .
Descriptive statistics and data analyses
Hypotheses were tested with moderated multiple regressions. Predictors were Attachment Anxiety, Attachment Avoidance (both mean centered), Treatment (dummy coded: 0 = placebo; 1 = oxytocin), and all possible two-way and threeway interactions. Significant interactions involving treatment were interpreted in two ways. First, regression models were computed with reverse-coded dummy for treatment (i.e., 0 = oxytocin; 1 = placebo), the logic being that main effects for attachment anxiety and/or attachment avoidance reflect an effect under placebo, and in the reverse-coded dummy regressions reflect an effect under oxytocin (Aiken and West, 1991) . Second, simple slopes at AE1SD for attachment avoidance (and attachment anxiety where relevant) were estimated. All hypotheses were tested at p < 0.05 (two-tailed).
Cooperation, trust, and betrayal aversion
In a first set of regressions, cooperation, trust, and betrayal aversion served as dependent variables. Table 2 summarizes a Attachment anxiety and avoidance are coded from low (1) to high (5). b Treatment is dummy coded with 0 = placebo and 1 = oxytocin. # p < 0.10 (two-tailed, with N = 77). * p < 0.05 (two-tailed, with N = 77). ** p < 0.01 (two-tailed, with N = 77).
3 The Adult Attachment Scale ratings for attachment security and attachment anxiety predicted the choice of Hazan and Shaver's (1987) the results and shows, first of all, a significant Attachment Avoidance Â Treatment effect for cooperation. The main effect for Attachment Avoidance was significant too, B = À1.155, SE = 0.408, t = À2.828, p < 0.006, indicating that when males were given placebo, those lower in attachment avoidance more often cooperated than those higher in attachment avoidance. A regression with reversed dummy coding for Treatment showed no effect for attachment avoidance when males received oxytocin, B = 0.390, SE = 0.408, t = 0.955, p < 0.343. Put differently, participants with low attachment avoidance (À1SD) cooperated somewhat less when given oxytocin rather than placebo, B = À0.774, SE = 0.413, t = À1.874, p < 0.10; participants with high attachment avoidance (+1SD) cooperated significantly more when given oxytocin rather than placebo, B = 0.864, SE = 0.424, t = 2.037, p < 0.045 (see also Fig. 1A ). This confirms Hypothesis 1.
With regard to trust, a similar pattern of results emerged. Table 2 shows a significant Attachment Avoidance Â TreatTreatment effect for trust, with a main effect for Attachment Avoidance, B = À1.368, SE = 0.333, t = À4.107, p < 0.001, indicating that when males were given placebo, those lower in attachment avoidance reported more trust than those higher in attachment avoidance. A regression with reversed dummy coding for Treatment showed no effect for attachment avoidance when males received oxytocin, B = 0.257, SE = 0.333, t = 0.772, p < 0.443. Put differently, participants with low attachment avoidance (À1SD) showed no effect of treatment, B = À0.515, SE = 0.337, t = À1.527, p < 0.131; participants with high attachment avoidance (+1SD) reported more trust when given oxytocin rather than placebo, B = 1.208, SE = 0.346, t = 3.493, p < 0.001 (see also Fig. 1B ). This confirms Hypothesis 2a.
For betrayal aversion, results showed a significant Attachment Avoidance Â Treatment interaction (see Table 2 ). The significant main effect for attachment avoidance in this model indicates that under placebo, males with lower attachment avoidance had lower betrayal aversion than those with higher attachment avoidance, B = 1.323, SE = 0.373, t = 3.546, p < 0.001. A regression with reversed dummy coding for treatment showed no effect for attachment avoidance when males received oxytocin, B = À0.048, SE = 0.373, t = À0.129, p < 0.897. Put differently, participants with low attachment avoidance (À1SD) showed no effect for treatment, B = 0.412, SE = 0.337, t = 1.093, p < 0.278; participants with high attachment avoidance (+1SD) showed lower betrayal aversion when given oxytocin rather than placebo, B = À1.040, SE = 0.387, t = À2.687, p < 0.009 (see Fig. 1C ). This confirms Hypothesis 2a.
Because of its patterning, betrayal aversion qualifies as a possible mediator between attachment avoidance and treatment on the one hand, and cooperation on the other. Indeed, betrayal aversion correlated with cooperation (see Table 1 ), and a regression with cooperation as dependent, and betrayal aversion as control variable showed a significant reduction in explained variance for cooperation compared to the model in which betrayal aversion was not controlled for, Sobel Z = 2.222, p < 0.0262. Specifically, when controlling for betrayal aversion, the Attachment Avoidance Â TreatTreatment interaction on cooperation is no longer significant, B = 0.844, SE = 0.539, t = 1.567, p < 0.122, the main effect for attachment avoidance also drops to non-significance, B = À0.479, SE = 0.395, t = À1.211, p < 0.230, and the main effect for betrayal aversion is significant, B = À0.512, SE = 0.117, t = À4.389, p < 0.001. This confirms Hypothesis 3a.
Taken together, results confirm Hypotheses 1, 2a, and 3a. When given placebo, males with lower attachment avoidance reported more trust and reduced betrayal aversion, and therefore cooperated more often than males with higher attachment avoidance; when given oxytocin, attachment avoidance no longer associated with trust, betrayal aversion, and cooperation.
Affiliation and post-task mood
In a second set of regressions, affiliation and post-task mood states (feeling at ease, happiness, hostility) served as dependent variables. For hostility, no effects were significant (all t < 0.981, all p > 0.327). For happiness, results only showed a three-way interaction among attachment anxiety, attachment avoidance, and treatment, B = 1.732, SE = 0.621, t = 2.790, p < 0.01. Follow-up analyses revealed no lower order effects whatsoever (all t < 1.301, all p > 0.192), prohibiting an interpretation of this unanticipated and complex effect. Table 3 summarizes the results for affiliation and feeling at ease. With regard to affiliation (Hypothesis 1b), results showed an unanticipated main effect for Attachment Anxiety, qualified by an Attachment Anxiety Â Attachment Avoidance interaction. Simple slopes analyses at AE1SD of attachment avoidance showed no relationship between attachment anxiety and affiliation among participants with high attachment avoidance, B = 0.117, SE = 0.237, t = 0.429, p < 0.669; among participants low in attachment avoidance, however, attachment anxiety negatively predicted affiliation tendencies, B = À1.109, SE = 0.396, t = À2.799, p < 0.007. Because treatment did not interact with attachment avoidance in predicting affiliation tendencies, affiliation does not qualify as a possible mediator between attachment avoidance and treatment on the one hand, and cooperation on the other. Indeed, a regression with cooperation as dependent, and affiliation tendencies as control variable showed no significant reduction in explained variance for cooperation compared to the model in which affiliation was not controlled for, Sobel Z = 0.18, p < 0.772. Both Hypothesis 1b and Hypothesis 3b need to be rejected.
With regard to feeling at ease, results showed significant Attachment Anxiety Â Treatment, and Attachment Avoidance Â Treatment interactions (see Table 3 ). Under placebo, main effects for attachment anxiety, and attachment avoidance, indicated that participants with lower attachment anxiety and/or attachment avoidance felt more at ease than those with higher attachment anxiety and/or attachment avoidance (see Table 3 ). A regression with reversed dummy coding for Treatment showed no main effects for attachment anxiety, B = À0.121, SE = 0.165, t = À0.731, p < 0.468, or for attachment avoidance, B = À0.157, SE = 0.169, t = À0.931, p < 0.355, when males received oxytocin. Put differently, participants with low attachment avoidance (À1SD) showed no effect for treatment, B = À0.222, SE = 0.176, t = À1.263, p < 0.221; participants with high attachment avoidance Table 3 Regression of affiliation tendencies, betrayal aversion, and feeling at ease on attachment anxiety (anxious), attachment avoidance (avoidant), treatment, and their interactions. (+1SD) felt more at ease when given oxytocin rather than placebo, B = 0.619, SE = 0.171, t = 3.620, p < 0.001 (see Fig. 2A ). 
Predictors
Feelings of attachment
The results for feeling at ease fit earlier studies showing that oxytocin modulates feelings of attachment (Buchheim et al., 2009; Bartz et al., 2010a) . Indeed, tabulating participant choices for the Hazan and Shaver (1987; HS) measure of attachment given at the end of experiment, showed that more participants given oxytocin rather than placebo chose HS-Secure, and fewer participants given oxytocin chose the HS-Anxious or HS-Avoidant, x 2 (1, N = 77) = 4.741, p < 0.030 (see Fig. 2B ). Thus, oxytocin increases feeling at ease especially among individuals with higher attachment avoidance, and directly improves feelings of secure attachment.
Conclusions and discussion
To survive and prosper in interpersonal encounters, humans need to detect whether unknown protagonists are trustworthy and likely to reciprocate cooperative effort or, instead, are untrustworthy and likely to exploit others. To predict others' behavioral tendencies, humans rely on cognitive-emotional schemas that are formed across the lifespan and position the individual on two broad dimensions of attachment -attachment anxiety, and attachment avoidance. Especially attachment avoidance is relevant here, as it typically associates with representations of others as essentially untrustworthy, undependable, and unreliable (Bowlby, 1973; Mikulincer and Shaver, 2007) . Indeed, the current experiment showed that healthy males scoring high rather than low on attachment avoidance trusted less an unknown protagonist, feared betrayal more, and less often decided to approach their protagonist cooperatively. Importantly, however, these effects of attachment avoidance disappeared when males received, prior to decision-making, intranasal oxytocin rather than placebo. Especially those high in attachment avoidance had higher trust, lower betrayal aversion, and they cooperated more when given oxytocin rather than placebo.
There are three possible explanations for these findings. First, the availability of oxytocin in the brain may promote affiliation tendencies and as individuals high in attachment avoidance are chronically low in affiliation tendencies, it is especially them who benefit from exogenous oxytocin. This possibility was, however, not supported in the current experiment-oxytocin did not interact with attachment avoidance in predicting affiliation tendencies (e.g., desire for future interaction) and affiliation did not statistically mediate effects of oxytocin and attachment avoidance on cooperation. Second, the availability of oxytocin may reduce general feelings of fear and distress , and this could affect especially individuals high rather than low in attachment avoidance (and attachment anxiety) (Buchheim et al., 2009) . Lowered fear and distress allows individuals to consider other behavioral strategies than ''fight-or-flight,'' and thus creates room for cooperative approach. This possibility is unlikely because (i) it is difficult to see why this process operates for attachment avoidance but not for attachment anxiety, and attachment anxiety did not relate to trust, betrayal aversion, and cooperation (see also below); and (ii) attachment avoidance and oxytocin interacted to predict feeling at ease, yet feeling at ease did not statistically mediate between attachment avoidance and oxytocin on the one hand, and cooperation on the other.
The third possible explanation proceeds on the basis of the assumption that the availability of oxytocin in the brain alters cognitive-emotional schemas of others as untrustworthy, undependable, and unreliable into more benevolent views of others (Bartz et al., 2011) . Indeed, intranasal oxytocin makes people less aversive of angry faces (Evans et al., 2010) , more likely to accept allies displaying high -rather than low threat (De Dreu et al., 2011b) , it de-activates neural circuitries associated with betrayal aversion (Baumgartner et al., 2008) , increases perceived facial trustworthiness and attractiveness (Theodoridou et al., 2009) , and activates neural circuitries associated with empathy such as the inferior frontal gyrus and the ventromedial prefrontal cortex Figure 2 (A) Oxytocin leads to stronger feeling at ease than placebo among individuals high (+1SD) but not low (À1SD) in attachment avoidance. (B) Oxytocin leads individuals to select secure attachment scenarios more, and insecure attachment scenarios less, than placebo. (Riem et al., 2011; Shamay-Tsoory, 2011) . Because it is especially individuals high in attachment avoidance who act on those negative scripts, it is especially them who might benefit from exogenous oxytocin. This possibility received some support in the current experiment-oxytocin interacted with attachment avoidance to predict trust and betrayal aversion, and betrayal aversion statistically mediated effects of oxytocin and attachment avoidance on cooperation. Further support for this possible explanation would come from new research showing that oxytocin interacts with attachment avoidance in altering the neural circuitries involved in, and the cognitive schemas used in person perception and impression formation (e.g., Amodio and Frith, 2006) .
Attachment avoidance provides a model of others' dependability and trustworthiness, and interacted here with oxytocin in predicting trust and cooperation. Attachment anxiety provides a model of the self as being unworthy of others' love and generosity, and did not interact here with oxytocin in predicting trust and cooperation. Other studies did, however, observe meaningful interactions between oxytocin and attachment anxiety. For example, Bartz et al. (2010a) found that intranasal oxytocin increased benevolent recollections of maternal care among individuals low in attachment anxiety, and negative recollections among individuals high in attachment anxiety. In another study, Bartz et al. (2010b) observed that especially among individuals high in attachment anxiety, oxytocin increased trust in a cooperative protagonist among individuals low in attachment avoidance, yet decreased trust in a cooperative protagonist among individuals high in attachment avoidance.
Whereas in the current study, the protagonist was unknown and no feedback about his behavioral choices were provided, in those studies showing interactions among attachment anxiety and oxytocin, such information was available-participants were thinking about their mother's availability (Bartz et al., 2010a) , or were provided with feedback showing their protagonist cooperated on previous rounds of the decision making game (Bartz et al., 2010b) . Whereas in the current study, participants' main task was to predict what their unknown protagonist might do, participants in the Bartz et al. studies at least also had to interpret and make sense of the target's behavior. Seen this way, one may speculate that oxytocin interacts with attachment avoidance primarily in altering mental models of others, thus affecting feelings of dependency and estimates of others' trustworthiness. Similarly, one may speculate that oxytocin interacts with attachment anxiety primarily in altering the interpretation of others' behavioral tendencies, such that potentially ambivalent behavior is interpreted more positively among low attachment anxiety individuals given oxytocin, and more negatively among high attachment individuals given oxytocin.
That oxytocin modulates prediction among individuals high in attachment avoidance, and interpretation and sense-making among individuals high in attachment anxiety, fits the results of recent neuro-imaging studies. These showed that when one's protagonist cooperated, oxytocin increased the caudate nucleus response, and this may facilitate the learning that another person can be trusted (Rilling et al., 2011) . Future research could test the hypothesis that this effect emerges especially among individuals high rather than low in attachment anxiety, and is not contingent upon attachment avoidance. The other way around, that oxytocin modulates prediction especially among individuals high rather than low in attachment avoidance fits the finding that oxytocin reduces amygdala activity and attenuated its coupling to brainstem centers responsible for autonomic and behavioral components of fear (Kirsch et al., 2005; Petrovic et al., 2008 ; also see Baumgartner et al., 2008) . Future research could test the hypothesis that these effects emerge especially among individuals high rather than low in attachment avoidance, and are not contingent upon attachment anxiety.
The use of neuropeptide administration permits conclusions about the causal effects of oxytocin, thus complementing studies showing that blood plasma oxytocin correlates with feelings of attachment (e.g., Tops et al., 2007; Marazziti et al., 2009; Strathearn et al., 2009 ) and/or attachmentrelated thoughts and behaviors (Feldman et al., 2007 Gordon et al., 2010) . Whereas neuropeptide administration provides unequivocal evidence that the availability of brain oxytocin moderates the relationship between attachment avoidance and cooperative cognition and behavior, correlational studies allow for reverse causality -that cooperative cognition and behavior interacts with feelings of attachment to predict levels of peripheral and/or central oxytocin. Indeed, in postmenopausal women, elevated plasma oxytocin significantly associates with gaps in social relationships, with less positive relationships with a primary partner, and with elevated cortisol levels , and Marazziti et al. (2009) observed a positive correlation between attachment anxiety in close relationships and blood plasma oxytocin. Possibly then, stress and rejection-related thoughts are physiologically down-regulated by hypothalamic release of oxytocin, allowing the individual to respond to stressful events -including interaction with unknown others -in more constructive manners than through immediate fight-or-fly (Taylor et al., 2000; Taylor, 2006) .
Current results show that enhanced availability of oxytocin in the brain increases constructive approach among individuals high more than among those low in attachment avoidance. Together with the finding that stress is downregulated by oxytocin release, this suggests the intriguing possibility that neural circuitries in individuals high in attachment avoidance not necessarily respond differentially to oxytocin release than those low in attachment avoidance. Instead, current findings suggest that it is the hypothalamic production of oxytocin that is differentially regulated in individuals high rather than low in attachment avoidance. This question requires new research, that could then also examine whether individuals high in attachment avoidance have relatively low oxytocin release in general, or whether their oxytocin release is triggered by different contexts than oxytocin release in individuals low in attachment avoidance.
Notwithstanding these and related questions for new research, current findings subscribe to the emerging insight that there is an intimate and reciprocal connection between neurobiological circuitries and life-span development of chronic individual differences in affiliation and social approach tendencies (Depue and Morrone-Strupinsky, 2005) . Oxytocin is a critical mediator between parenting behaviors and the development of infant attachment (Feldman et al., 2007 Gordon et al., 2010) , that through social interactions are reinforced as children mature into adults (Bowlby, 1973; Mikulincer and Shaver, 2007) . In adults, exogenous oxytocin increases feelings of secure attachment (Buchheim et al., 2009) , and among those high in attachment avoidance, elevating oxytocin reduces betrayal aversion and increases trust and cooperation (current findings). Importantly, higher rates of cooperation are potentially rewarding and stimulating long-term constructive exchange-as a result of treatment with oxytocin, high attachment avoidance individuals engage in a constructive and potentially mutually rewarding exchange, and this in itself may facilitate the development of stronger social bonds, generalized trust and, perhaps, secure attachment. Oxytocin not only mediates parent-child bonding and the development of infant attachment. Among adults lacking secure attachment, oxytocin reduces fear and betrayal aversion, and facilitates the development of trust and constructive social exchange.
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